Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Reckitt
Reckitt
Activities:
Body Care
Skin Care
Pharmaceutical
X
LinkedIn
Trending Articles
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Adare expands global handling & packaging capabilities
The company will have enhanced compaction, milling, bin blending and tablet compression capabilities in Philadelphia, Ohio and Milan
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Making the most of each cell: single-use perfusion in biopharma processing
GEA kytero perfusion disk stack separators are pioneering the time- and cost-efficient harvesting of pharmaceutical proteins from cells and facilitating continuous processing,...
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Manufacturing
Kemtile appointed as a single-source supplier by Reckitt
Kemtile, a division of Stonhard, has been appointed as a single-source supplier to design and install a new flooring solution for production area corridors at Reckitt (formerly Reckitt Benckiser) in Nottingham, UK
Design & Build
M+W Group starts building RB’s new Centre for Scientific Excellence in UK
Groundwork has already begun on the R&D Centre in Dansom Lane, Hull, that will provide a GMP development facility and pilot plant
Regulatory
Australian Federal Court finds Reckitt Benckiser made misleading claims about content of its painkillers
Orders Nurofen Specific Pain product range to be removed from retail shelves
Finance
Reckitt Benckiser to spin off its pharmaceuticals business
Will be renamed Indivior and continue to concentrate on treatments for opioid addiction
You need to be a subscriber to read this article.
Click here
to find out more.
Regulatory
Competition Law is catching pharma companies out
With major multinationals paying a high price for illegal and corrupt market activities, Paul Henty and Rory Ashmore, of legal firm Speechly Bircham, review the underlying causes and the risks
Media
Reckitt Benckiser licenses Atrigel Technology from QTL
<p>Reckitt Benckiser Pharmaceuticals Inc, based in Richmond, VA, has set up a licensing agreement with QLT USA, for Atrigel sustained-release drug delivery technology.</p>
Subscribe now